Effects of concurrent Helicobacter pylori infection and small intestinal bacterial overgrowth on the gut microbiota and metabolic profiles: A multi-omics study
Acta Microbiologica et Immunologica Hungarica · 29.05.2026 · 73 (2) · 201-210
DOI: 10.1556/030.2026.02894 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Microbiologica et Immunologica Hungarica, erschienen am 29.05.2026. Verfasst von Yu-Cheng Zhu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361015, China. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori, Intestine, Small, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
This study investigated the synergistic effects of Helicobacter pylori ( Hp ) infection and small intestinal bacterial overgrowth (SIBO) on the gut microbiota structure and metabolic profiles and elucidate the underlying pathophysiological mechanisms. Forty-two patients with gastrointestinal symptoms were recruited and assigned to group A ( Hp + SIBO + ), B ( Hp + SIBO − ), C ( Hp − SIBO + ), or D ( Hp − SIBO − ) based on their Hp infection and SIBO status. Fecal samples were collected for metagenomic sequencing and untargeted metabolomic analysis. The associations between microbiota and metabolites were evaluated using alpha/beta diversity analysis, differential species screening, metabolite identification, and Procrustes/Spearman correlation analysis. Neither Hp infection nor SIBO significantly altered the alpha or beta diversity of the gut microbiota (both P > 0.05). However, specific shifts in microbial abundance were observed. Specifically, the abundance of short-chain fatty acid-producing bacteria such as Megamonas was significantly decreased in the SIBO + groups. Metabolomic analysis revealed significant enrichment of inflammatory metabolites ( e.g. , prostaglandin derivatives) in group A, disordered bile acid conjugates ( e.g. , chenodeoxycholylisoleucine) and nucleotide metabolism in SIBO + groups, and abnormal lipid/carbohydrate metabolism pathways in Hp + groups. Multi-omics integration analysis indicated a strong coupling between the microbial structure and metabolic profiles (Procrustes analysis, P < 0.05). In group A, the abundance of Faecalibacterium and Hominenteromicrobium was negatively correlated with bile acid levels, suggesting impaired bile acid transformation. Hp infection and SIBO might synergistically exacerbate gut ecological and metabolic disorders by reshaping specific microbiota and metabolic networks (enhanced inflammatory response, disrupted bile acid circulation). Their co-occurrence produces additive effects, which could explain the aggravated clinical symptoms. This study provides a theoretical basis for interventions targeting microbiota–metabolite interactions, such as probiotics and bile acid modulators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361015, China.
ORCID-Profile: Yan Deng, Jia-Qi Zeng
Zitieren
APA
Zhu, Y. C., Deng, Y., & Zeng, J. Q. (2026). Effects of concurrent Helicobacter pylori infection and small intestinal bacterial overgrowth on the gut microbiota and metabolic profiles: A multi-omics study. Acta Microbiologica et Immunologica Hungarica, 73(2), 201-210. https://doi.org/10.1556/030.2026.02894
Vancouver
Zhu YC, Deng Y, Zeng JQ. Effects of concurrent Helicobacter pylori infection and small intestinal bacterial overgrowth on the gut microbiota and metabolic profiles: A multi-omics study. Acta Microbiologica et Immunologica Hungarica. 2026;73(2):201-210. doi:10.1556/030.2026.02894
BibTeX
@article{Zhu2026,
author = {Zhu, Yu-Cheng and Deng, Yan and Zeng, Jia-Qi},
title = {Effects of concurrent Helicobacter pylori infection and small intestinal bacterial overgrowth on the gut microbiota and metabolic profiles: A multi-omics study},
journal = {Acta Microbiologica et Immunologica Hungarica},
year = {2026},
volume = {73},
number = {2},
pages = {201--210},
doi = {10.1556/030.2026.02894}
}
EUVIMED